The use of oseltamivir during an influenza B outbreak in a chronic care hospital

被引:19
|
作者
Seale, Holly [1 ]
Weston, Kathryn M. [2 ]
Dwyer, Dominic E. [3 ,4 ]
Zhu, Mengzhi
Allchin, Lisa [2 ]
Booy, Robert [5 ]
MacIntyre, C. Raina [1 ,5 ]
机构
[1] Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW 2052, Australia
[2] Ctr Populat Hlth, Sydney W Area Hlth Serv, Publ Hlth Unit, Sydney, NSW, Australia
[3] Westmead Hosp, Ctr Infect Dis, Westmead, NSW 2145, Australia
[4] Westmead Hosp, Microbiol Lab Serv, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia
[5] Univ Sydney, Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW 2006, Australia
关键词
Influenza; oseltamivir; antiviral; hospital; vaccination; outbreak; NEURAMINIDASE INHIBITOR OSELTAMIVIR; RANDOMIZED CONTROLLED-TRIALS; NURSING-HOMES; ANTIVIRAL THERAPY; VACCINATION; PREVENTION; WORKERS; CHEMOPROPHYLAXIS; IMMUNIZATION; POPULATION;
D O I
10.1111/j.1750-2659.2008.00063.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Residents of nursing homes and long-term care facilities are at a higher risk of outbreaks of influenza and of serious complications of influenza than those in the community. In late July 2005, a 90-bed chronic care psycho-geriatric hospital in Sydney, Australia, reported cases of influenza-like illness (ILI) occurring amongst its residents. Methods An investigation to confirm the outbreak, and its cause, was undertaken. Influenza vaccination levels amongst residents, and the effects of antiviral drugs used for prevention and treatment, were assessed. Oseltamivir was only given to the residents, in the form of both treatment and prophylaxis. Results A total of 22 out of 89 residents met the clinical case definition of ILI with onset on or after 27 July 2005. This represents an attack rate of 25%. Oseltamivir was commenced on day 9 of the outbreak. Influenza B was identified in six residents as the causative agent of the outbreak. No deaths or acute hospitalization were recorded for this outbreak and there were no further reported cases after the introduction of oseltamivir. Vaccine effectiveness was 75% and the strain of influenza B isolated was well matched to that year's vaccine. Conclusions There are few data on the use of oseltamivir in influenza B outbreaks. Early antiviral intervention appeared to curtail this outbreak of influenza B in a chronic care facility. We found high vaccine effectiveness in this frail, institutionalized population, highlighting the importance of influenza vaccination for residents of chronic care facilities.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [41] Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit
    Yue, Mimi C.
    Collins, Joel T.
    Subramoniapillai, Elango
    Kennedy, Glen A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (01) : 37 - 43
  • [42] Use of Oseltamivir to control influenza complications after bone marrow transplantation
    Machado, CM
    Boas, LSV
    Mendes, AVA
    da Rocha, IF
    Sturaro, D
    Dulley, FL
    Pannuti, CS
    BONE MARROW TRANSPLANTATION, 2004, 34 (02) : 111 - 114
  • [43] Benign Acute Childhood Myositis During Influenza B Outbreak
    Szenborn, L.
    Toczek-Kubicka, K.
    Zaryczanski, J.
    Marchewka-Kowalik, M.
    Miskiewicz, K.
    Kuchar, E.
    CURRENT CONCEPTS IN MEDICAL RESEARCH AND PRACTICE, 2018, 1039 : 29 - 34
  • [44] Use of Oseltamivir to control influenza complications after bone marrow transplantation
    C M Machado
    L S V Boas
    A V A Mendes
    I F da Rocha
    D Sturaro
    F L Dulley
    C S Pannuti
    Bone Marrow Transplantation, 2004, 34 : 111 - 114
  • [45] Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
    de Mario Marin, Marcia Lucia
    do Carmo Oliveira, Bruno Barbosa
    Cipriano, Sonia Lucena
    Suslik, Carlos Alberto
    Faintuch, Joel
    CLINICS, 2010, 65 (11) : 1081 - 1086
  • [46] Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study
    Konstantinos Z. Vardakas
    George Theocharis
    Giannoula S. Tansarli
    Petros Rafailidis
    Matthew E. Falagas
    Archives of Virology, 2016, 161 : 2511 - 2518
  • [47] Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians
    Jessica R. Cataldi
    Laura P. Hurley
    Megan C. Lindley
    Sean T. O’Leary
    Carol Gorman
    Michaela Brtnikova
    Brenda L. Beaty
    Lori A. Crane
    David K. Shay
    Allison Kempe
    Journal of General Internal Medicine, 2021, 36 : 2030 - 2038
  • [48] Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians
    Cataldi, Jessica R.
    Hurley, Laura P.
    Lindley, Megan C.
    O'Leary, Sean T.
    Gorman, Carol
    Brtnikova, Michaela
    Beaty, Brenda L.
    Crane, Lori A.
    Shay, David K.
    Kempe, Allison
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (07) : 2030 - 2038
  • [49] Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000
    Bowles, SK
    Lee, W
    Simor, AE
    Vearncombe, M
    Loeb, M
    Tamblyn, S
    Fearon, M
    Li, Y
    McGeer, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : 608 - 616
  • [50] Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic
    Xie, Hai-yan
    Yasseen, Abdool S., III
    Xie, Ri-hua
    Fell, Deshayne B.
    Sprague, Ann E.
    Liu, Ning
    Smith, Graeme N.
    Walker, Mark C.
    Wen, Shi Wu
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (04) : 293.e1 - 293.e7